clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT04011410 |
P6099 | clinical trial phase | phase II clinical trial | Q42824440 |
P17 | country | United States of America | Q30 |
P582 | end time | 2021-05-01 | |
P921 | main subject | metastatic prostate carcinoma | Q55779807 |
Oligometastatic prostate cancer and salvage lymph node dissection: systematic review | Q57112655 | ||
P2899 | minimum age | 18 | |
P1132 | number of participants | 20 | |
P580 | start time | 2019-07-01 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | Phase 2 Study of Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer |
Search more.